Clinical Trials

Phase EARLY_PHASE1 Completed

Leukemia, Myeloid, Myelodysplastic Syndromes

NCT04628338 2025-04-29

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

8 enrolled

Phase EARLY_PHASE1 Recruiting

Graft vs Host Disease, Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03964506 2025-04-04

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

24 enrolled

Phase EARLY_PHASE1 Completed

Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT06904859 2025-04-01

The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia

50 enrolled

Hematologic Diseases, Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT05282459 2025-03-20

Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation

Phase 1/2 Completed

17 enrolled

Leukemia, Leukemia, Monocytic, Acute, Leukemia, Myeloid

NCT01050036 2025-03-17

Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia

20 enrolled

Leukemia, Myeloid

NCT06643962 2024-11-12

Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy

Phase NA Recruiting

83 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04714372 2024-10-24

FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia

9 enrolled 16 charts

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT03613727 2023-11-07

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Classical hematologyOther hematologic neoplasm

61 enrolled 11 charts

Anemia, Refractory, with Excess of Blasts, Graft vs Host Disease, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid

NCT02916979 2023-10-18

FluBuATG

LymphoidMyeloidOther hematologic neoplasmPlasma cell

20 enrolled

Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Primary Myelofibrosis

NCT01411267 2022-04-04

AC220 for Children With Relapsed/Refractory ALL or AML

LymphoidOther hematologic neoplasm

24 enrolled 14 charts

Leukemia, Leukemia, Myeloid, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04039100 2022-02-08

Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease

LymphoidOther hematologic neoplasmPlasma cell

43 enrolled

Hematologic Diseases, Leukemia, Myeloid, Lymphoma, Multiple Myeloma, Neoplasms

NCT01841333 2022-01-25

PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant

31 enrolled 10 charts

Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT01861002 2021-06-09

A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML

LymphoidOther hematologic neoplasm

15 enrolled 10 charts

Leukemia, Leukemia, Myeloid, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03197714 2021-02-15

Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia

9 enrolled

DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT01643603 2020-12-17

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Phase 1 Terminated

5 enrolled

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

NCT02763475 2020-10-05

NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents

7 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT03417427 2020-04-27

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Phase 2 Unknown

100 enrolled

Pathologic Complete Response, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT02370888 2020-01-27

UF-BMT-MRD-101

Phase 1 Terminated

11 enrolled 3 charts

Leukemia, Myeloid, Myelodysplastic Syndromes

NCT02719821 2019-11-15

Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation

LymphoidMyeloidOther hematologic neoplasmPlasma cell

17 enrolled

Depression, Fatigue, Hodgkin Disease, Sleep Initiation and Maintenance Disorders, Leukemia, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes

NCT02955043 2019-11-15

Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery

LymphoidMyeloidOther hematologic neoplasmPlasma cell

39 enrolled

Depression, Fatigue, Hodgkin Disease, Sleep Initiation and Maintenance Disorders, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes

NCT00568633 2019-09-24

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Phase 3 Terminated

58 enrolled 18 charts

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT00780104 2019-07-12

UPCC 02407

16 enrolled

Leukemia, Leukemia, Myeloid

NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Classical hematologyMyeloidOther hematologic neoplasm

44 enrolled 13 charts

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

NCT00065143 2018-11-07

Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

60 enrolled

Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00038597 2018-10-30

Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)

13 enrolled

Bronchiolitis Obliterans Syndrome, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT02333838 2018-08-13

TBF-Cord

Phase 2 Unknown

31 enrolled

Leukemia, Myeloid

NCT00611247 2018-06-15

Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia

42 enrolled 8 charts

Leukemia, Myeloid

NCT01779882 2018-03-02

Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT

72 enrolled

Leukemia, Myeloid

NCT03114670 2017-06-14

Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT

Phase 1 Unknown

20 enrolled

Leukemia, Leukemia, Myeloid, Neoplasms by Histologic Type, Recurrence, Leukemia, Myeloid, Acute, Disease Attributes

NCT03080922 2017-04-04

High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML

Phase 1/2 Unknown

10 enrolled

Leukemia, Myeloid, Recurrence, Leukemia, Myeloid, Acute

NCT00943943 2017-03-29

Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations

33 enrolled

Phase EARLY_PHASE1 Completed

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT01174940 2017-01-09

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

22 enrolled

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02047149 2016-09-30

Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia

Phase 1 Terminated

2 enrolled

Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00133367 2016-07-25

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

LymphoidOther hematologic neoplasmPlasma cell

32 enrolled

Graft vs Host Disease, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01864902 2016-01-28

CART33

Phase 1/2 Unknown

10 enrolled